FVLIX
Price
$20.19
Change
-$0.01 (-0.05%)
Updated
Jun 5 closing price
Net Assets
27.72M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.22B
Interact to see
Advertisement

FVLIX vs RMEBX

Header iconFVLIX vs RMEBX Comparison
Open Charts FVLIX vs RMEBXBanner chart's image
Fidelity Advisor Value Leaders I
Price$20.19
Change-$0.01 (-0.05%)
VolumeN/A
Net Assets27.72M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.22B
FVLIX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FVLIX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FVLIX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. FVLIX (27.7M). FVLIX pays higher dividends than RMEBX: FVLIX (1.53) vs RMEBX (1.16). FVLIX was incepted earlier than RMEBX: FVLIX (22 years) vs RMEBX (11 years). RMEBX (1.07) and FVLIX (1.06) have similar cost to investors . FVLIX (32.00) and RMEBX (31.00) have comparable annual turnover. FVLIX has a lower initial minimum investment than RMEBX: FVLIX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. FVLIX (-8.52). RMEBX return over 5 years is better than : 49.85 vs. FVLIX (25.55).
FVLIXRMEBXFVLIX / RMEBX
Total Expense Ratio0.901.0784%
Annual Report Gross Expense Ratio1.061.0799%
Fund Existence22 years11 years-
Gain YTD0.0005.349-
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets27.7M105B0%
Annual Yield % from dividends1.531.16132%
Returns for 1 year-8.528.30-103%
Returns for 3 years-1.4617.96-8%
Returns for 5 years25.5549.8551%
Returns for 10 years26.8968.2139%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA